Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0B | 1.7B | 1.9B | 1.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.5B | 1.4B | 1.4B | 1.4B |
Operating income | 367M | 216M | 385M | 374M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 36M | — | 40M | — |
Other income expense | — | — | — | — |
Pretax income | 319M | 170M | 326M | 322M |
Tax provision | 75M | 34M | 78M | 77M |
Net income | 244M | 136M | 248M | 245M |
Basic EPS | 2.5 | 1.3 | 2.5 | 2.5 |
Diluted EPS | 2.5 | 1.3 | 2.5 | 2.5 |
Basic average shares | 99.6M | 99.2M | 99.6M | 99.6M |
Diluted average shares | 99.7M | 99.2M | 100M | 99.6M |
EBITDA | 499M | 368M | 505M | 510M |
Net income from continuing op. | 319M | 170M | 326M | 322M |
Minority interests | 7M | -7M | 2M | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |